Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | EGLN3 |
Upstream (Parents) |
---|
(<<) ENO2 → EGLN3 |
(<<) ALDOA → EGLN3 |
(<<) NDRG1 → EGLN3 |
Downstream (Children) |
---|
EGLN3 → ADM (>>) |
EGLN3 → FOSL2 (>>) |
EGLN3 → SLC2A3 (>>) |
EGLN3 → NDRG4 (>>) |
EGLN3 → GNA11 (>>) |
EGLN3 → MEX3D (>>) |
EGLN3 → NEDD9 (>>) |
EGLN3 → CLTCL1 (>>) |
EGLN3 → HPCAL4 (>>) |
EGLN3 → PFKFB3 (>>) |